FDA PMA FDA Class 3 Approved 🇺🇸 United States

Excimer Laser System

PMA: P020050 · Supplement: S043 · Decision Mar 5, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P020050 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Excimer Laser System
Trade Name
WaveLight EX500 Laser
PMA Number
P020050
Supplement Number
S043
Device Class
FDA Class 3
Product Code
LZS
Generic Name
Excimer laser system
Medical Specialty
Unknown
Advisory Committee
Ophthalmic
Decision
Approved
Decision Code
APPR
Decision Date
March 5, 2025
Date Received
October 31, 2023
Supplement Type
Panel Track
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Approval for the WaveLight EX500 laser system, in conjunction with INNOVEYES Sightmap, is indicated for use in INNOVEYES Laser Assisted In-Situ Keratomileusis (“wavelight plus” LASIK) treatments:• for the reduction or elimination of myopia or myopia with astigmatism, in eyes with spherical equivalent (SE) more than -1.00 and up to -9.00 diopters (D), with up to -8.00 D of spherical component (in minus cylinder format) and up to -3.00 D of astigmatic component at the spectacle plane, based on the INNOVEYES Sightmap Measured Refraction,• in patients with magnitude of the spherical equivalent (SE) difference between the Manifest Refraction (MRSE) and the Sightmap measured refraction SE being less than 0.75D,• in patients who are 18 years of age or older, and• for patients with documentation of a stable manifest refraction defined as </= 0.5 D preoperative spherical equivalent shift over one year prior to surgery.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LZS Excimer Laser System